Cost of end-of-life care for cancer varies between countries Clinical study 30 January 2016 Pages: 13 - 13
Deferiprone cost saving for iron overload in thalassaemia Clinical study 30 January 2016 Pages: 14 - 14
Disease activity-guided TNFi therapy cost saving for RA Clinical study 30 January 2016 Pages: 15 - 15
FEV1 is indicator of economic impact of cystic fibrosis Clinical study 30 January 2016 Pages: 16 - 16
Idelalisib + rituximab good value for relapsed/refractory CLL Clinical study 30 January 2016 Pages: 17 - 17
Inadequate contraception in adolescents prescribed teratogens Clinical study 30 January 2016 Pages: 18 - 18
Mammography screening for early BC cost effective in Turkey Clinical study 30 January 2016 Pages: 20 - 20
New model shows economic benefits of aTIV versus TIV or QIV Clinical study 30 January 2016 Pages: 22 - 22
Nilotinib provides better outcomes at lower cost in Ph+ CML-CP Clinical study 30 January 2016 Pages: 23 - 23
Pharmacists' interventions reduce costs, improve safety Clinical study 30 January 2016 Pages: 27 - 27
Telephone genetic counseling less costly in underserved areas Clinical study 30 January 2016 Pages: 33 - 33
Ward closure cost effective for control of norovirus in UK Clinical study 30 January 2016 Pages: 35 - 35